| Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy E Crabtree, K Uribe, SM Smith, D Roberts, JH Salmon, JJ Bower, L Song, ... Plos one 17 (8), e0270972, 2022 | 13 | 2022 |
| In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs D Roberts, HVT Cotter, M Cubeta, BC Gilger Veterinary ophthalmology 23 (5), 918-922, 2020 | 11 | 2020 |
| Intracorneal sequential dosing of AAV-ArsB clears corneal opacity associated with mucopolysaccharidosis VI in a feline model BC Gilger, JH Salmon, D Roberts, L Song, J Bower, M Hirsch Investigative Ophthalmology & Visual Science 62 (8), 801-801, 2021 | 4 | 2021 |
| Immunomodulatory gene therapy for treatment of ocular graft vs host disease J Nilles, D Roberts, B Salmon, M Hirsch, BC Gilger Investigative Ophthalmology & Visual Science 62 (8), 798-798, 2021 | 2 | 2021 |
| Phase-Dependent Differential In Vitro and Ex Vivo Susceptibility of Aspergillus flavus and Fusarium keratoplasticum to Azole Antifungals D Roberts, J Salmon, MA Cubeta, BC Gilger Journal of Fungi 9 (10), 966, 2023 | | 2023 |
| AAV-mediated expression of HLA-G for the prevention of experimental Ocular Graft vs Host Disease JP Nilles, D Roberts, JH Salmon, L Song, C O’Dea, LT Marjoram, ... Molecular Therapy-Methods & Clinical Development, 2023 | | 2023 |
| An ex vivo porcine cornea-based assay as a model for predicting equine keratitis fungi drug sensitivity D Roberts, C Ludwig, M Cullen, JH Salmon, M Cubeta, BC Gilger Investigative Ophthalmology & Visual Science 63 (7), 1301–F0116-1301–F0116, 2022 | | 2022 |
| Titration of x-ray whole body radiation dose to optimize the murine model of ocular graft vs host disease JH Salmon, J Nilles, D Roberts, BC Gilger Investigative Ophthalmology & Visual Science 62 (8), 738-738, 2021 | | 2021 |
| Subconjunctival AAV8-optHLA-G1&5 for Treatment of Ocular Graft vs Host Disease B Gilger, J Nilles, D Roberts, M Hirsch MOLECULAR THERAPY 29 (4), 271-272, 2021 | | 2021 |
| Intracorneal and Sequential Contralateral Dosing of AAV-opt-ARSB Reverses MPS VI Corneal Clouding ML Hirsch, JH Salmon, L Song, D Roberts, JJ Bower, P Bastola, BC Gilger MOLECULAR THERAPY 29 (4), 67-67, 2021 | | 2021 |
